Conexeu Sciences Inc.
CNXUNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $106.54M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.05$18.79
- Volume (live)
- -
- Avg. volume (3M)
- 279.08K
Conexeu Sciences (CNXU) Stock Price & Financial Analysis
Conexeu Sciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.05 - $4.00 |
|---|---|
| 52-Week High | $18.79 |
| 52-Week Low | $3.05 |
| Open | $3.96 |
| Volume (last close) | 663.90K |
| Average Volume (3M) | 279.08K |
| 50-Day MA | $5.72 |
|---|
| Market Cap | 106.54M |
|---|---|
| Shares Outstanding | 26.97M |
| Price to Book (P/B) | 18.21 |
| EV/EBITDA | -7.66 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Conexeu Sciences at a Glance
As of the Oct 16, 2026 close, Conexeu Sciences (CNXU) has a market capitalization of $106.54M.
As of its latest reported balance sheet, it holds $1.97M in cash and securities against $33.23K of debt, a net cash position of $1.94M.
Conexeu Sciences does not currently pay a dividend.
At $3.06 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $3.05 to $18.79.
Frequently Asked Questions About Conexeu Sciences
What is the current stock price for CNXU?
As of the Oct 16, 2026 close, CNXU stock trades at $3.06. The 52-week range is $3.05–$18.79, with a day range of $3.05–$4.00.
What is the P/E ratio for CNXU?
The P/E ratio (Price-to-Earnings) for CNXU is shown in the Key Statistics section. This valuation metric helps compare Conexeu Sciences Inc. to industry peers.
Does CNXU pay dividends?
Conexeu Sciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CNXU?
Analyst ratings and recommendations for CNXU are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CNXU?
As of the Oct 16, 2026 close, Conexeu Sciences's market capitalization is $82.5M, classifying it as a micro-cap company. Conexeu Sciences operates in the Healthcare sector within the Biotechnology industry.